Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Acorda Therapeutics Company Profile (NASDAQ:ACOR)

Consensus Ratings for Acorda Therapeutics (NASDAQ:ACOR) (?)
Ratings Breakdown: 5 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.44)
Consensus Price Target: $38.42 (12.53% upside)

Analysts' Ratings History for Acorda Therapeutics (NASDAQ:ACOR)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/9/2014ZacksReiterated RatingNeutral -> Neutral$34.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2014Stifel NicolausInitiated CoverageBuy$47.00ViewTweet This Rating  Share This Rating on StockTwits
8/4/2014ZacksReiterated RatingNeutral -> Neutral$30.00ViewTweet This Rating  Share This Rating on StockTwits
5/7/2014MKM PartnersLower Price TargetNeutral$33.00 -> $31.50ViewTweet This Rating  Share This Rating on StockTwits
5/6/2014AegisReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
5/5/2014Citigroup Inc.Reiterated RatingHold$34.00ViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
4/17/2014Canaccord GenuityInitiated CoverageHold$37.00ViewTweet This Rating  Share This Rating on StockTwits
4/14/2014FBR Capital MarketsUpgradeMarket Perform -> Outperform$30.00 -> $47.00ViewTweet This Rating  Share This Rating on StockTwits
1/6/2014Citigroup Inc.DowngradeBuy -> Neutral$37.00 -> $33.00ViewTweet This Rating  Share This Rating on StockTwits
11/1/2013FBR & CoUpgradeMkt Perform -> OutperformViewTweet This Rating  Share This Rating on StockTwits
11/1/2013MKM PartnersUpgradeSell -> Neutral$33.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
11/1/2013FBR Capital MarketsLower Price TargetOutperform$35.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
10/30/2013FBR Capital MarketsInitiated CoverageMarket Perform$35.00ViewTweet This Rating  Share This Rating on StockTwits
10/1/2013AegisBoost Price TargetBuy$43.00 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
8/2/2013Cowen and CompanyBoost Price Target$37.73 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
8/1/2013Feltl & Co.Boost Price TargetBuy$40.00 -> $43.00ViewTweet This Rating  Share This Rating on StockTwits
5/2/2013MKM PartnersDowngradeNeutral -> SellViewTweet This Rating  Share This Rating on StockTwits
4/16/2013RBC CapitalBoost Price Target$38.00 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
4/16/2013MKM PartnersBoost Price TargetNeutral$31.00 -> $33.00ViewTweet This Rating  Share This Rating on StockTwits
4/15/2013AegisBoost Price TargetBuy$34.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
1/8/2013MKM PartnersDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Citigroup Inc.UpgradeNeutral -> Buy$28.00 -> $33.00ViewTweet This Rating  Share This Rating on StockTwits
10/8/2012RBC CapitalReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/2/2012 forward)
Discuss Acorda Therapeutics